Ironwood Pharmaceuticals, Inc. provided earnings guidance for the year 2022. For the year, the company expects total revenue to be in the range of $420 million to $430 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.08 USD | -0.25% | +6.32% | -29.37% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.37% | 1.26B | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.70% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- IRWD Stock
- News Ironwood Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc. Provides Earnings Guidance for the Year 2022